Draegerwerk AG & Co. KGaA (DE:DRW8)
XETRA:DRW8
Want to see DE:DRW8 full AI Analyst Report?
DRW8 Stock Chart & Stats
€55.60
€0.60(1.43%)
At close: 4:00 PM EST
€55.60
€0.60(1.43%)
Day’s Range― - ―
52-Week Range€50.00 - €77.40
Previous CloseN/A
Volume225.00
Average Volume (3M)3.38K
Market Cap
€1.36B
Enterprise Value€1.48B
Total Cash (Recent Filing)€269.09M
Total Debt (Recent Filing)€225.68M
Price to Earnings (P/E)37.3
Beta0.61
Next Earnings
Jul 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.46%
Share Statistics
EPS (TTM)8.17
Shares Outstanding10,160,000
10 Day Avg. Volume2,278
30 Day Avg. Volume3,385
Financial Highlights & Ratios
PEG Ratio0.74
Price to Book (P/B)0.80
Price to Sales (P/S)0.37
P/FCF Ratio7.81
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)7.75
Revenue Forecast (FY)€3.61B
Bulls Say, Bears Say
Bulls Say
Conservative LeverageVery low debt-to-equity and a sizable equity base provide durable financial flexibility: supports funding of higher capex/lease investments, dividend policy, and shields operations from cyclical shocks. This balance-sheet strength reduces refinancing risk and preserves strategic optionality over months to years.
Revenue Recovery & Order GrowthA clear multi-year recovery with record sales and rising order intake signals sustained demand and backlog visibility, improving medium-term revenue predictability. Broad-based order growth across divisions and regions underpins capacity utilization and supports continued service and consumable follow-on revenue streams.
Positive Cash GenerationMaterial positive operating and free cash flow that meaningfully covers earnings provides sustainable internal funding for capex, share repurchases or dividends. Even with some volatility, consistent positive FCF improves self-financing ability for investments and reduces dependency on external financing over the medium term.
Bears Say
Thin Profitability MarginsRelatively modest EBIT and net margins leave limited buffer against cost, tariff or currency shocks and reduce capital available for reinvestment. For a medical/safety technology business, subpar margin resilience constrains ability to fund R&D and price competition while maintaining targeted returns over the medium term.
Volatile Cash ConversionHistoric swings in operating and free cash flow suggest working-capital and reinvestment timing can materially alter available cash. That volatility raises execution risk for multi-year projects, weakens predictability of shareholder returns, and can pressure liquidity during periods of slower revenue or higher capex.
Tariff, FX And Investment-driven Debt RiskPersistent external headwinds (tariffs, currency) directly compress margins, while planned higher capex and a long-term leased distribution center will increase reported net debt/lease liabilities. Together they raise the risk of lower profitability and reduced financial flexibility if macro/trade pressures persist.
Draegerwerk AG & Co. KGaA News
DRW8 FAQ
What was Draegerwerk AG & Co. KGaA’s price range in the past 12 months?
Draegerwerk AG & Co. KGaA lowest stock price was €50.00 and its highest was €77.40 in the past 12 months.
What is Draegerwerk AG & Co. KGaA’s market cap?
Draegerwerk AG & Co. KGaA’s market cap is €1.36B.
When is Draegerwerk AG & Co. KGaA’s upcoming earnings report date?
Draegerwerk AG & Co. KGaA’s upcoming earnings report date is Jul 30, 2026 which is in 74 days.
How were Draegerwerk AG & Co. KGaA’s earnings last quarter?
Draegerwerk AG & Co. KGaA released its earnings results on Apr 30, 2026. The company reported €0.62 earnings per share for the quarter, the consensus estimate of €0.62 by €0.
Is Draegerwerk AG & Co. KGaA overvalued?
According to Wall Street analysts Draegerwerk AG & Co. KGaA’s price is currently Overvalued.
Does Draegerwerk AG & Co. KGaA pay dividends?
Draegerwerk AG & Co. KGaA pays a Annually dividend of €1.97 which represents an annual dividend yield of 3.46%. See more information on Draegerwerk AG & Co. KGaA dividends here
What is Draegerwerk AG & Co. KGaA’s EPS estimate?
Draegerwerk AG & Co. KGaA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Draegerwerk AG & Co. KGaA have?
Draegerwerk AG & Co. KGaA has 10,160,000 shares outstanding.
What happened to Draegerwerk AG & Co. KGaA’s price movement after its last earnings report?
Draegerwerk AG & Co. KGaA reported an EPS of €0.62 in its last earnings report, expectations of €0.62. Following the earnings report the stock price went up 1.157%.
Which hedge fund is a major shareholder of Draegerwerk AG & Co. KGaA?
Currently, no hedge funds are holding shares in DE:DRW8
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Draegerwerk AG & Co. KGaA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
9.79%
Trailing 12-Months
Asset Growth
3.14%
Trailing 12-Months
Company Description
Draegerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as fire training facilities for firefighters. Drägerwerk AG & Co. KGaA was founded in 1889 and is headquartered in Lübeck, Germany.
Technical Analysis
Carl Zeiss Meditec
―
Eckert & Ziegler Strahlen und Medizintechnik
―
MeVis Medical Solutions
―
STRATEC Biomedical
―
Siemens Healthineers AG
―
Options Prices
Currently, No data available
---